Section
Pipeline
Late-stage drugs with significant commercial implications
PipelineEndpoints News ↗
A new HIV treatment will soon come to market, and it will spearhead Merck’s attempt to be one of the leading d…
PipelineSTAT News ↗
At AACR, a bold use of CAR-T raises hopes and provocative questions about its use in smoldering multiple myelo…
PipelineBriefing
Enflonsia, now cleared across the EU and EEA, promises single-dose, five-month protection against RSV, positio…
PipelineBioPharma Dive ↗
Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug develop…
PipelineSTAT News ↗
You're reading the web version of STAT's popup newsletter, AACR in 30 seconds, your guide to what's happening …
PipelineFierceBiotech ↗
The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundre…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.